Eliem Therapeutics Inc (ELYM)
7.86
-0.34
(-4.15%)
USD |
NASDAQ |
May 21, 16:00
7.86
0.00 (0.00%)
After-Hours: 20:00
Eliem Therapeutics Free Cash Flow: -7.241M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -7.241M |
| December 31, 2023 | -20.60M |
| September 30, 2023 | -28.10M |
| June 30, 2023 | -35.77M |
| March 31, 2023 | -41.77M |
| December 31, 2022 | -37.37M |
| September 30, 2022 | -36.80M |
| Date | Value |
|---|---|
| June 30, 2022 | -45.60M |
| March 31, 2022 | -40.11M |
| December 31, 2021 | -36.07M |
| September 30, 2021 | -33.81M |
| June 30, 2021 | -23.23M |
| March 31, 2021 | -18.51M |
| December 31, 2020 | -14.10M |
Free Cash Flow Range, Past 5 Years
-45.60M
Minimum
Jun 2022
-7.241M
Maximum
Mar 2024
-29.93M
Average
-34.79M
Median
Free Cash Flow Benchmarks
| Alpine Immune Sciences Inc | -80.96M |
| Candel Therapeutics Inc | -32.19M |
| Cyclacel Pharmaceuticals Inc | -9.734M |
| Lipocine Inc | -5.530M |
| GlycoMimetics Inc | -33.81M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.819M |
| Cash from Investing (Quarterly) | 13.75M |
| Cash from Financing (Quarterly) | 0.015M |
| Free Cash Flow Per Share (Quarterly) | -0.0658 |
| Free Cash Flow Yield | -3.38% |